Mammalian myeloid progenitor cell subsets
Patent Number: 7,300,760
Date of First Priority Issue: Tuesday June 29th, 1999
Date Issued: Tuesday November 27th, 2007
Assignee: The Board of Trustees of the Leland Stanford Junior University (Palo Alto, CA)
Inventors: Weissman; Irving L. (Redwood City, CA), Traver; David Jeffrey (West Roxbury, MA), Akashi; Koichi (Boston, MA), Manz; Markus Gabriel (Palo Alto, CA), Miyamoto; Toshihiro (Menlo Park, CA)
From Class: Type
Comments: No comments
This patent covers a method of extracting or substantially purifying for cells having myeloid stem cell potential. The method covers the selection of cells that are Thy-1 negative, interleukin-7 negative, and lineage negative. By lineage negative the claim means the cells not expressing CD2; CD3; CD4; CD7; CD8; CD10; CD11b; CD14; CD19; CD20; CD56; and glycophorin A (GPA).
View this patent on the USPTO website.
Added to StemCellPatents.com on Sunday December 2nd, 2007
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.